Clinical Trials Sponsored by Agenus Inc.

Total 37339 results

British Columbia Cancer Agency

Unknown

Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy (FTPC)

Prostate Cancer

Canada
International Atomic Energy Agency

Completed

Optimization of Radiotherapy in Treatment of Painful Bone Metastasis (bone mets)

Pain | Bone Metastasis

Egypt, Spain, Serbia, Algeria, Brazil, India, Lithuania, Macedonia, The Former Yugoslav Republic of, Mexico, Tunisia, United Kingdom
British Columbia Cancer Agency

Completed

Feasibility of VMAT and CBCT for Head and Neck Carcinomas

Head and Neck Carcinoma

Canada
British Columbia Cancer Agency

Completed

Can 3D Ultrasound Be Used Reproducibly by Radiation Therapists in Partial Breast Image-Guided Radiation Therapy (IGRT)

Radiation Therapy for Primary Breast Cancer

Canada
International Atomic Energy Agency

Completed

CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

Cervix Cancer

Peru, Korea, Republic of, Morocco, Austria, Brazil, Canada, India, Macedonia, The Former Yugoslav Republic of, Pakistan, South Africa, United Kingdom
International Atomic Energy Agency

Completed

Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia

Esophageal Cancer

China, Canada, Croatia, India, Pakistan, South Africa, Thailand
Environmental Protection Agency (EPA)

Completed

Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles

Healthy

United States
British Columbia Cancer Agency

Completed

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

Hormone Refractory Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Acupuncture in Palliative Cancer Care

Neoplasms | Palliative Care

Canada
British Columbia Cancer Agency

Completed

A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer

Adenocarcinoma of the Prostate

Canada
British Columbia Cancer Agency

Recruiting

Evidence Development in Cancer Treatment - Real World: PREDiCTrw

Cancer

Canada
British Columbia Cancer Agency

Not yet recruiting

Diagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT Simulation (dCT-PRT)

Bone Metastases
British Columbia Cancer Agency

Not yet recruiting

Preliminary Assessment of [18F]BL40 in PET/CT Scans

Multiple Myeloma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma

Canada
British Columbia Cancer Agency

Not yet recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

B-cell Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell Leukemia | B-cell Acute Lymphoblastic Leukemia | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | High-grade B-cell Lymphoma

Canada
British Columbia Cancer Agency

Recruiting

CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease

Non Small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal Metastasis

Canada
International Atomic Energy Agency

Recruiting

FDG an Myocardial Infarction: The PIAF Trial (PIAF)

History of Myocardial Infarction

United States
British Columbia Cancer Agency

Recruiting

A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer

Ovarian Cancer | Platinum-resistant Ovarian Cancer

Canada
British Columbia Cancer Agency

Recruiting

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) (PROMPT)

Oligometastatic Prostate Cancer

Canada
British Columbia Cancer Agency

Not yet recruiting

Dynamic Whole Body PET/ MRI

Prostatic Cancer

Canada
British Columbia Cancer Agency

Recruiting

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Prostatic Neoplasms | Prostate Cancer | Neuroendocrine Tumors | Neuroblastoma | Carcinoid Tumor | Paraganglioma

Canada
British Columbia Cancer Agency

Recruiting

Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease (OPTiMAL)

Prostate Cancer

Canada
British Columbia Cancer Agency

Active, not recruiting

Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant (PBSI)

Early Stage Breast Cancer

Canada
British Columbia Cancer Agency

Active, not recruiting

Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases

Brain Metastases

Canada
British Columbia Cancer Agency

Completed

MSG Use With 18F-DCFPyL PET/CT Imaging

Prostate Cancer | Prostate Cancer Metastatic | Prostatic Neoplasm

Canada
British Columbia Cancer Agency

Terminated

PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

Breast Cancer

Canada
British Columbia Cancer Agency

Completed

CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse (Vitesse)

Prostate Cancer | Interstitial Radiation | High Dose Rate Brachytherapy | Ultrasound-based Planning Compared to CT-based Planning

Canada
Environmental Protection Agency (EPA)

Completed

Effects of Sequential Exposure to Nitrogen Dioxide and Ozone in Healthy Adult Human Volunteers. (ENDZONE)

Respiratory Depression

United States
British Columbia Cancer Agency

Completed

Sequencing Abiraterone and Enzalutamide in mCRPC

Metastatic Castration-Resistant Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy

Prostate Cancer

Canada
British Columbia Cancer Agency

Terminated

Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients

Cancer | Constipation

Canada
British Columbia Cancer Agency

Terminated

CEST- Glucose Enhanced MRI for Metastatic Brain Tumours

Metastasis | Brain Neoplasms, Malignant

Canada
British Columbia Cancer Agency

Unknown

Intensity Modulated Versus Interstitial - Radiation Therapy

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy

Hepatocellular Carcinoma

Canada
British Columbia Cancer Agency

Completed

Biomarker - Panitumumab Response With KRAS Wild Type MCC

Metastatic Colorectal Cancer

Canada
British Columbia Cancer Agency

Completed

Do Skin Markings Reflect the Location of the Surgical Cavity During Daily Radiotherapy Treatment?

Breast Cancer

Canada
British Columbia Cancer Agency

Unknown

Remote Psychosocial Intervention for Brain Tumour Survivors

Quality of Life
Environmental Protection Agency (EPA)

Completed

Interaction Effects of Temperature and Ozone (TROPICOZ)

Exposure to Environmental Pollution, Non-occupational

United States
International Atomic Energy Agency

Completed

Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy

Non Small Cell Lung Cancer

Chile, China, Croatia, Egypt, India, Malaysia, Malta, Morocco, Pakistan, Panama, Peru, South Africa, Tunisia
Environmental Protection Agency (EPA)

Completed

Cardiopulmonary Responses to Exposure to Ozone and Diesel Exhaust (DEPOZ)

Blood Pressure | Respiratory Depression

United States
British Columbia Cancer Agency

Unknown

Screening Methods in Finding Lung Cancer Early in Current or Former Smokers (Pan Can)

Tobacco Use Disorder | Lung Cancer

Canada
International Atomic Energy Agency

Unknown

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

Cancer of the Cervix

India, South Africa, Tanzania, Uganda, Zimbabwe
British Columbia Cancer Agency

Completed

Neuropathic Pain Caused by Radiation Therapy (NP)

Neuropathic Pain Secondary to Radiation Therapy

Canada
ICF Macro, Inc.
United States Agency for International Development (USAID); Uganda Bureau of...

Completed

Comparison of Blood Sampling Methods for Hemoglobin Measurement

Anemia

Uganda
Lenus Therapeutics, LLC

Terminated

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa (CELEB)

Dystrophic Epidermolysis Bullosa | Junctional Epidermolysis Bullosa

United States
Venus Remedies Limited

Completed

CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria (PLEA)

Acute Pyelonephritis | Urinary Tract Infection Complicated

India
Herlev Hospital
GENIS

Terminated

Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (CHIPAC)

Pancreatic Cancer

Denmark
Herlev Hospital
GENIS

Terminated

Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN) (CHITIN)

Advanced Solid Tumors

Denmark
Oregon Health and Science University
Agency for Healthcare Research and Quality (AHRQ); OCHIN, Inc.

Completed

Post Affordable Care Act Evaluation (PACE)

Chronic Disease

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States

Clinical Trials Sponsored by Agenus Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations